Sahota Surinder S, Forconi Francesco, Ottensmeier Christian H, Provan Drew, Oscier David G, Hamblin Terry J, Stevenson Freda K
Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals, Southampton, United Kingdom.
Blood. 2002 Aug 15;100(4):1505-7.
There exists a wide spectrum of IgM-secreting B-cell tumors with different clinical behavior. Knowledge of the V(H) gene status can reveal their origin and clonal history. For Waldenstrom macroglobulinemia (WM), a distinct subtype of lymphoplasmacytic lymphoma, early data on limited sequences showed evidence for somatic mutation. A recent report of one case demonstrated intraclonal mutational activity occurring after transformation, a characteristic of germinal center lymphomas. To extend the investigation, we have analyzed 7 cases of WM. V(H) genes were somatically mutated with no evidence of intraclonal variation in all cases. In contrast to IgM-secreting multiple myeloma, there was no evidence for isotype switch transcripts in any of the cases. These data support the concept that typical WM is derived from a B cell that has undergone somatic mutation prior to transformation, at a point where isotype switch events have not been initiated. (Blood. 2002;100:1505-1507)
存在一系列具有不同临床行为的分泌IgM的B细胞肿瘤。了解V(H)基因状态能够揭示它们的起源和克隆史。对于华氏巨球蛋白血症(WM),这是一种淋巴浆细胞淋巴瘤的独特亚型,关于有限序列的早期数据显示了体细胞突变的证据。最近一份关于一个病例的报告表明,在转化后出现了克隆内突变活性,这是生发中心淋巴瘤的一个特征。为了扩展研究,我们分析了7例WM。所有病例中V(H)基因均发生体细胞突变,且无克隆内变异的证据。与分泌IgM的多发性骨髓瘤不同,所有病例中均未发现同种型转换转录本的证据。这些数据支持了这样一种概念,即典型的WM源自一个在转化前已经历体细胞突变的B细胞,此时同种型转换事件尚未启动。(《血液》。2002年;100:1505 - 1507)